Literature DB >> 28768724

PD-L2 Regulates B-1 Cell Antibody Production against Phosphorylcholine through an IL-5-Dependent Mechanism.

Jerome T McKay1, Marcela A Haro1, Christina A Daly1, Rama D Yammani1, Bing Pang1, W Edward Swords1, Karen M Haas2.   

Abstract

B-1 cells produce natural Abs which provide an integral first line of defense against pathogens while also performing important homeostatic housekeeping functions. In this study, we demonstrate that programmed cell death 1 ligand 2 (PD-L2) regulates the production of natural Abs against phosphorylcholine (PC). Naive PD-L2-deficient (PD-L2-/-) mice produced significantly more PC-reactive IgM and IgA. This afforded PD-L2-/- mice with selectively enhanced protection against PC-expressing nontypeable Haemophilus influenzae, but not PC-negative nontypeable Haemophilus influenzae, relative to wild-type mice. PD-L2-/- mice had significantly increased PC-specific CD138+ splenic plasmablasts bearing a B-1a phenotype, and produced PC-reactive Abs largely of the T15 Id. Importantly, PC-reactive B-1 cells expressed PD-L2 and irradiated chimeras demonstrated that B cell-intrinsic PD-L2 expression regulated PC-specific Ab production. In addition to increased PC-specific IgM, naive PD-L2-/- mice and irradiated chimeras reconstituted with PD-L2-/- B cells had significantly higher levels of IL-5, a potent stimulator of B-1 cell Ab production. PD-L2 mAb blockade of wild-type B-1 cells in culture significantly increased CD138 and Blimp1 expression and PC-specific IgM, but did not affect proliferation. PD-L2 mAb blockade significantly increased IL-5+ T cells in culture. Both IL-5 neutralization and STAT5 inhibition blunted the effects of PD-L2 mAb blockade on B-1 cells. Thus, B-1 cell-intrinsic PD-L2 expression inhibits IL-5 production by T cells and thereby limits natural Ab production by B-1 cells. These findings have broad implications for the development of therapeutic strategies aimed at altering natural Ab levels critical for protection against infectious disease, autoimmunity, allergy, cancer, and atherosclerosis.
Copyright © 2017 by The American Association of Immunologists, Inc.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 28768724      PMCID: PMC5587397          DOI: 10.4049/jimmunol.1700555

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  132 in total

1.  Survival of bacterial biofilms within neutrophil extracellular traps promotes nontypeable Haemophilus influenzae persistence in the chinchilla model for otitis media.

Authors:  Wenzhou Hong; Richard A Juneau; Bing Pang; W Edward Swords
Journal:  J Innate Immun       Date:  2009-02-27       Impact factor: 7.349

2.  Naturally secreted immunoglobulins limit B1 and MZ B-cell numbers through a microbiota-independent mechanism.

Authors:  Andreia C Lino; Elodie Mohr; Jocelyne Demengeot
Journal:  Blood       Date:  2013-05-30       Impact factor: 22.113

Review 3.  Btk function in B cell development and response.

Authors:  A B Satterthwaite; Z Li; O N Witte
Journal:  Semin Immunol       Date:  1998-08       Impact factor: 11.130

4.  Novel theranostic opportunities offered by characterization of altered membrane lipid metabolism in breast cancer progression.

Authors:  Mika Hilvo; Carsten Denkert; Laura Lehtinen; Berit Müller; Scarlet Brockmöller; Tuulikki Seppänen-Laakso; Jan Budczies; Elmar Bucher; Laxman Yetukuri; Sandra Castillo; Emilia Berg; Heli Nygren; Marko Sysi-Aho; Julian L Griffin; Oliver Fiehn; Sibylle Loibl; Christiane Richter-Ehrenstein; Cornelia Radke; Tuulia Hyötyläinen; Olli Kallioniemi; Kristiina Iljin; Matej Oresic
Journal:  Cancer Res       Date:  2011-03-17       Impact factor: 12.701

5.  Primate B-1 cells generate antigen-specific B cell responses to T cell-independent type 2 antigens.

Authors:  Rama D Yammani; Karen M Haas
Journal:  J Immunol       Date:  2013-03-01       Impact factor: 5.422

6.  The role of IL-5 for mature B-1 cells in homeostatic proliferation, cell survival, and Ig production.

Authors:  Byoung-gon Moon; Satoshi Takaki; Kensuke Miyake; Kiyoshi Takatsu
Journal:  J Immunol       Date:  2004-05-15       Impact factor: 5.422

7.  PD-L2 expression extends beyond dendritic cells/macrophages to B1 cells enriched for V(H)11/V(H)12 and phosphatidylcholine binding.

Authors:  Xuemei Zhong; Joseph R Tumang; Wenda Gao; Chunyan Bai; Thomas L Rothstein
Journal:  Eur J Immunol       Date:  2007-09       Impact factor: 5.532

8.  B-1a B cells that link the innate and adaptive immune responses are lacking in the absence of the spleen.

Authors:  Hedda Wardemann; Thomas Boehm; Neil Dear; Rita Carsetti
Journal:  J Exp Med       Date:  2002-03-18       Impact factor: 14.307

9.  BAFF, a novel ligand of the tumor necrosis factor family, stimulates B cell growth.

Authors:  P Schneider; F MacKay; V Steiner; K Hofmann; J L Bodmer; N Holler; C Ambrose; P Lawton; S Bixler; H Acha-Orbea; D Valmori; P Romero; C Werner-Favre; R H Zubler; J L Browning; J Tschopp
Journal:  J Exp Med       Date:  1999-06-07       Impact factor: 14.307

10.  Octamer binding protein 2 (Oct2) regulates PD-L2 gene expression in B-1 cells through lineage-specific activity of a unique, intronic promoter.

Authors:  H Kaku; T L Rothstein
Journal:  Genes Immun       Date:  2009-08-27       Impact factor: 2.676

View more
  16 in total

Review 1.  B Cell Activation and Response Regulation During Viral Infections.

Authors:  Jonathan H Lam; Fauna L Smith; Nicole Baumgarth
Journal:  Viral Immunol       Date:  2020-04-23       Impact factor: 2.257

2.  B Cell Subsets Differentially Contribute to the T Cell-Independent Memory Pool.

Authors:  Christina A Daly; M Ariel Spurrier; Jamie E Jennings-Gee; Karen M Haas
Journal:  J Immunol       Date:  2020-09-25       Impact factor: 5.422

3.  Sex Influences Age-Related Changes in Natural Antibodies and CD5+ B-1 Cells.

Authors:  Sarah E Webster; Brinda Ryali; Michael J Clemente; Naomi L Tsuji; Nichol E Holodick
Journal:  J Immunol       Date:  2022-03-07       Impact factor: 5.422

4.  The PD-1 Regulatory Axis Inhibits T Cell-Independent B Cell Memory Generation and Reactivation.

Authors:  M Ariel Spurrier; Jamie E Jennings-Gee; Christina A Daly; Karen M Haas
Journal:  J Immunol       Date:  2021-09-17       Impact factor: 5.426

5.  An Adjuvant That Increases Protective Antibody Responses to Polysaccharide Antigens and Enables Recall Responses.

Authors:  James P Phipps; Karen M Haas
Journal:  J Infect Dis       Date:  2019-01-07       Impact factor: 5.226

6.  CD22 Promotes B-1b Cell Responses to T Cell-Independent Type 2 Antigens.

Authors:  Karen M Haas; Kristen L Johnson; James P Phipps; Cardinal Do
Journal:  J Immunol       Date:  2018-01-26       Impact factor: 5.422

Review 7.  B-1 cell responses to infections.

Authors:  Fauna L Smith; Nicole Baumgarth
Journal:  Curr Opin Immunol       Date:  2019-01-24       Impact factor: 7.486

8.  Patients with systemic lupus erythematosus show increased proportions of CD19+CD20- B cells and secretion of related autoantibodies.

Authors:  Qingqing Zhu; Yun Li; Lili Zhang; Min Wang; Zhongxin Chen; Junxiang Shi; Ji Li; Baiqing Li; Zhijun Li; Yuanyuan Wang; Changhao Xie
Journal:  Clin Rheumatol       Date:  2020-06-15       Impact factor: 2.980

Review 9.  Role of B-cell receptors for B-cell development and antigen-induced differentiation.

Authors:  Juan Carlos Yam-Puc; Lingling Zhang; Yang Zhang; Kai-Michael Toellner
Journal:  F1000Res       Date:  2018-04-06

Review 10.  Programmed cell death-ligand 2: A neglected but important target in the immune response to cancer?

Authors:  Cinzia Solinas; Marco Aiello; Esdy Rozali; Matteo Lambertini; Karen Willard-Gallo; Edoardo Migliori
Journal:  Transl Oncol       Date:  2020-07-01       Impact factor: 4.243

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.